Article

Foldable intraocular telescope holds promise for patients with end-stage AMD

With approximately 14 million Americans with end-stage age-related macular degeneration (AMD), the latest developments in low vision aids for these patients is welcoming, noted Gholam A. Peyman, MD.

With approximately 14 million Americans with end-stage age-related macular degeneration (AMD), the latest developments in low vision aids for these patients is welcoming, noted Gholam A. Peyman, MD.

Dr. Peyman, professor of ophthalmology, Tulane University School of Medicine, New Orleans, described the steps leading up to the development of the Foldable Intraocular Telescope (FIT). He spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting.

In 1988, he presented the concept behind FIT, which is basically a posterior chamber IOL with a telescopic zone and peripheral zone.

"The patient will be able to have full peripheral visual field without spectacles," Dr. Peyman said. "If the patient would like to read, he uses the plus lens in the telescope and the minus lens inside the eye. It provides 2.4x magnification."

From this concept, the foldable version, FIT, was developed with bifocal capabilities. This 5.8-mm foldable IOL system consists of a telescope measuring 1.5 mm in diameter and 3.5 mm in height. A 4.5-mm corneal incision is need for its implantation, he said.

"FIT provides patients with 3x magnification. For the surgeon it provides easier implantation," he said.

Dr. Peyman also discussed the development of a power-adjustable contact lens for the correction of myopia, hyperopia, and astigmatism. One of the advantages of this lens is the ability to correct higher-order aberrations, Dr. Peyman said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.